Paper23908669
Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea.
Moon BS and 2 others. Korean J Pediatr, 2013. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea. Papers, record 23908669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23908669
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15569163 | A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia. | Haemophilia | 2004 | https://conductscience.org/library/papers/15569163 | PubMed |
| 2 | 17687129 | Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17687129 | PubMed |
| 3 | 19143924 | Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. | J Thromb Haemost | 2009 | https://conductscience.org/library/papers/19143924 | PubMed |
| 4 | 780375 | The history of haemophilia. | J Clin Pathol | 1976 | https://conductscience.org/library/papers/780375 | PubMed |
| 5 | 849938 | Hemophilic arthropathy. Current concepts of pathogenesis and management. | J Bone Joint Surg Am | 1977 | https://conductscience.org/library/papers/849938 | PubMed |
| 6 | 9873763 | When should prophylactic treatment in patients with haemophilia A and B start?--The German experience. | Haemophilia | 1998 | https://conductscience.org/library/papers/9873763 | PubMed |
| 7 | 5854304 | Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. | Acta Orthop Scand Suppl | 1965 | https://conductscience.org/library/papers/5854304 | PubMed |
| 8 | 16011583 | Thrombin generation and phenotypic correlation in haemophilia A. | Haemophilia | 2005 | https://conductscience.org/library/papers/16011583 | PubMed |
| 9 | 11136389 | What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? | Haemophilia | 2001 | https://conductscience.org/library/papers/11136389 | PubMed |
| 10 | 15660988 | Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters. | Haemophilia | 2005 | https://conductscience.org/library/papers/15660988 | PubMed |
| 11 | 16128885 | Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. | Haemophilia | 2005 | https://conductscience.org/library/papers/16128885 | PubMed |
| 12 | 9873783 | The destructive capabilities of the synovium in the haemophilic joint. | Haemophilia | 1998 | https://conductscience.org/library/papers/9873783 | PubMed |
| 13 | 12828668 | The pharmacokinetics of clotting factor therapy. | Haemophilia | 2003 | https://conductscience.org/library/papers/12828668 | PubMed |
| 14 | 27214717 | Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A. | Haemophilia | 1997 | https://conductscience.org/library/papers/27214717 | PubMed |
| 15 | 327532 | Hemophilia A prophylaxis with factor VIII concentrate in a home-treatment program: a controlled study. | Scand J Haematol Suppl | 1977 | https://conductscience.org/library/papers/327532 | PubMed |
| 16 | 11260054 | Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. | Br J Haematol | 2001 | https://conductscience.org/library/papers/11260054 | PubMed |
| 17 | 11895765 | The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. | Blood | 2002 | https://conductscience.org/library/papers/11895765 | PubMed |
| 18 | 1640190 | Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. | J Intern Med | 1992 | https://conductscience.org/library/papers/1640190 | PubMed |
| 19 | 12410643 | Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen. | Haemophilia | 2002 | https://conductscience.org/library/papers/12410643 | PubMed |
| 20 | 7408294 | A radiologic classification of hemophilic arthropathy. | Clin Orthop Relat Res | 1980 | https://conductscience.org/library/papers/7408294 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F8 | 2157 | PubTator's text mining | https://conductscience.org/library/genes/2157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23908669
GET https://conductscience.org/api/papers/v1/23908669/references?page=2